Urinary bladder cancer encompasses a spectrum of neoplasms ranging from low-grade papillary tumors to high-grade aggressive tumors. The majority of tumors are of the former type and characteristically recur following surgical resection. Our overall objective is to investigate both mechanisms of urinary bladder carcinogenesis and methods for prevention of recurrence of neoplasms. The immediate objective is to obtain evidence supporting our working hypothesis which states that """"""""the progression to cancer of initiated bladder epithelial cells is aided by factors which stimulate cell replication."""""""" The factors include the specific urinary components capable of inducing ornithine decarboxylase (ODC), and chemical and physical trauma stimulating continued or repeated regenerative hyperplasia.
The specific aims to test the hypothesis are: 1) to clarify the mechanism(s) of the inhibitory actions demonstrated by an irreversible inhibitor of ODC, Alpha-difluoromethylornithine, on carcinogenesis in the heterotopically transplanted urinary bladder system, 2) to determine whether the carcinogenesis in the natural bladder system can be similarly inhibited by chronic oral administration of DFMO, and 3) to determine whether the diffuse papillomatosis of the rat urinary bladder which develops in association with bladder calculi without known prior carcinogen exposure, is reversible following removal of the physical stimulus (calculus). These studies will be conducted using the heterotopically transplanted urinary bladder system developed in our laboratory, and natural bladders.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Chemical Pathology Study Section (CPA)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Northwestern University at Chicago
School of Medicine & Dentistry
United States
Zip Code
Maeda, Akinobu; Nakashiro, Koh-ichi; Hara, Shingo et al. (2006) Inactivation of AR activates HGF/c-Met system in human prostatic carcinoma cells. Biochem Biophys Res Commun 347:1158-65
Nakashiro, Koh-Ichi; Hara, Shingo; Shinohara, Yuji et al. (2004) Phenotypic switch from paracrine to autocrine role of hepatocyte growth factor in an androgen-independent human prostatic carcinoma cell line, CWR22R. Am J Pathol 165:533-40
Nakashiro, Koh-Ichi; Hayashi, Yoshiki; Oyasu, Ryoichi (2003) Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue. Oncol Rep 10:1149-53
Chlenski, A; Nakashiro , K; Ketels, K V et al. (2001) Androgen receptor expression in androgen-independent prostate cancer cell lines. Prostate 47:66-75
Nakashiro, K I; Hayashi, Y; Kita, A et al. (2001) Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells. Am J Pathol 159:591-7
Nakashiro, K; Okamoto, M; Hayashi, Y et al. (2000) Hepatocyte growth factor secreted by prostate-derived stromal cells stimulates growth of androgen-independent human prostatic carcinoma cells. Am J Pathol 157:795-803
Tamatani, T; Turk, P; Weitzman, S et al. (1999) Tumorigenic conversion of a rat urothelial cell line by human polymorphonuclear leukocytes activated by lipopolysaccharide. Jpn J Cancer Res 90:829-36
Tamatani, T; Hattori, K; Nakashiro, K et al. (1999) Neoplastic conversion of human urothelial cells in vitro by overexpression of H2O2-generating peroxisomal fatty acyl CoA oxidase. Int J Oncol 15:743-9
Okamoto, M; Webber, M M; Quader, S et al. (1998) Interleukin-6 and epidermal growth factor promote anchorage-independent growth of immortalized human prostatic epithelial cells treated with N-methyl-N-nitrosourea. Prostate 35:255-62
Okamoto, M; Hattori, K; Oyasu, R (1997) Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro. Int J Cancer 72:149-54

Showing the most recent 10 out of 30 publications